ORG Wealth Partners
VOR icon

ORG Wealth Partners’s Vor Biopharma VOR Stock Holding History

ORG Wealth Partners’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$171 Buy
+9
New +$192 ﹤0.01% 2379

Other funds holding VOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
NEXTBio Capital Management
NEXTBio Capital Management Menlo Park, California $234M AUM 176.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

ORG Wealth Partners's VOR Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Vor Biopharma (VOR) in Q3 2026: 9 shares worth $171. The stake represents ﹤0.01% of the portfolio and ranks #2379 among its holdings.

98 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • ORG Wealth Partners held 9 shares of Vor Biopharma worth $171 as of Q3 2026.
  • Vor Biopharma was a new ORG Wealth Partners position in Q3 2026.
  • Vor Biopharma made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2379 holding.
  • 98 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.